Loading data
HIPONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 468.6 m USD | 372.1 m USD | 209.7 m USD | 119.7 m USD | 91.2 m USD |
| Profit before tax | 63.3 m USD | -27.4 m USD | -262.5 m USD | -325.2 m USD | -367.2 m USD |
| Income tax expense | 700 k USD | 1.2 m USD | 500 k USD | 1.3 m USD | 700 k USD |
| Net income (reported basis) | 62.6 m USD | -28.6 m USD | -263 m USD | -333.4 m USD | -371.4 m USD |
| Net income attributable to common shareholders | 57.7 m USD | -40.5 m USD | -273.1 m USD | -333.4 m USD | -371.4 m USD |
| Basic earnings per share | 2.28 USD/share | -1.64 USD/share | -11.58 USD/share | -14.66 USD/share | -34.11 USD/share |
| Diluted earnings per share | 2.22 USD/share | -1.64 USD/share | -11.58 USD/share | -14.66 USD/share | -34.11 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.